Effective Date: April 7, 2023
Antidote’s core mission is to enable faster medical innovation, by transforming how sponsors and patients connect.
All other information collected from you may be used and shared with third parties on an anonymous or aggregated basis only. Your personally identifiable information is stored in our databases. You can access, modify, or permanently delete your records at any time. With your consent we may contact you from time to time about clinical trials that may suit your profile, to introduce new products, to share educational materials, to solicit patient stories after trials are completed, and for other reasons supporting our mission of helping patients find and access treatment options in development.
Antidote may contact you via equivalently secure registered third-party platforms, email, SMS text, web chat, or social media. Antidote does not exchange personally identifiable information through/via social media – nor do we sell or share your personally identifiable information with social media channels.
PLEASE NOTE THAT YOUR RELATIONSHIP WITH GOOGLE, SOCIAL MEDIA - NOT LIMITED TO TWITTER, TIKTOK, META (FACEBOOK, INSTAGRAM), OR ANY OTHER THIRD-PARTY WEBSITE; IS GOVERNED SOLELY BY YOUR AGREEMENT WITH SUCH THIRD-PARTY WEBSITE. ANY REGIONAL PRIVACY SETTINGS OR CONSENTING OF ONLINE TRACKING TECHNOLOGIES WITHIN THESE THIRD-PARTY WEBSITES IS NOT WITHIN THE CONTROL OF ANTIDOTE.
You can opt out of this service at any time and can choose to not use the Site.
Our website is not intended for children under 13 years of age. No one under age 13 may provide any personally identifiable information to or on the Site. We do not knowingly collect personally identifiable information from children under 13. If you are under 13, do not use or provide any information on this Site or on or through any of its features, and do not provide us with any information about yourself. If we learn we have collected or received personally identifiable information from a child under 13, we will delete that information.
If located in California or the European Economic Area, any child under the age of 16 years shall be restricted in the same regard.
Any information entered on behalf of a child under 13 years of age (or 16 years if located in California or the European Economic Area, or 18 years if located in Asia) must be strictly provided by a parent or legal guardian.
If you believe we might have any information from or about a child, please contact us at email@example.com.
The purpose of this Privacy Statement is to explain what Antidote does with personally identifiable information that you provide to us. We want you to know how your personally identifiable information will be protected, as well as under what circumstances we may share it, with whom, and for what purposes.
Many of Antidote’s services, such as browsing through our clinical trial database, do not require any form of registration or identification. You can freely visit many of our web pages without telling us who you are.
However, some of our services do require that you provide your personal details - including but not limited to your name, age, gender, racial or ethnic origin, contact details (mailing address/telephone number/email address), health information/history, medical records and demographics. With your consent; this allows us to contact you by telephone, email, SMS text, web chat or social media to:
Antidote does not sell and will not share your personally identifiable information without your consent.
You may update your preferences or opt out of any of these communications at any time by contacting us as directed below.
The information that we ask you to provide may include your first and last name, age, gender, racial or ethnic origin, contact details (mailing address/telephone number/email address), information relating to your medical conditions and history, biometrics and genetic profile.
Antidote limits the collection and processing of personally identifiable information and medical information to what is necessary to fulfill the purposes for which it is to be used.
Many of our customers register for more than one trial or service, through the Site, by calling Antidote, or through a third party, such as their healthcare provider or an Antidote partner. When you register with us more than once, we may combine your personally identifiable information with computer information gathered (see below) and store it collectively. This helps us keep track of all of your preferences in one organized place, so that we can provide information to you based on a more informed review of your requests and medical conditions of interest.
Antidote takes all reasonable steps to ensure that personally identifiable information collected is reliable for its intended use, accurate, complete, and current.
Antidote uses appropriate technical, administrative, and physical safeguards to protect data that pertains to you from loss, misuse, or alteration. In addition, we take steps to ensure that our safeguards take into account new known threats. Of course, no organization can guarantee the absolute security of personally identifiable information. You should keep in mind that Internet transmissions, particularly email transmissions, are never 100% secure or error-free. Accordingly, we also caution you to guard your own computer and password against unauthorized access by others.
Any detected breach of data security (accidental or unlawful access, disclosure or misuse of personally identifiable information) shall be reported without undue delay.
When you visit the Site or access our search tool through our partners, we do not collect any personally identifiable information about you without your permission. However, we do collect information about you if your computer is set to allow that type of collection. This includes IP address, device ID or fingerprint, Cookies, Web Beacons, Pixels, Tags (including server-to-server tag tracking such as Application Programming Interfaces ‘API’), and other similar online tracking technologies - depending on your location. You can turn off the ability to collect some of this information from your computer or device settings.
This type of information allows us to evaluate interest in our website and perform other market research analytics. It also allows us to track visitors to our website based on website advertisements about Antidote services. Please see our Cookies and Online Tracking Policy to learn more.
For information on how to opt out of third-party collection of information; please visit the Network Advertising Initiative’s (NAI) website - an independent website not sponsored by, or affiliated with Antidote.
We request your consent to collect your personally identifiable information when you seek to register for an Antidote program or service. In doing so, we also explain, for that program or service, what you are registering to receive and how we plan to use your personally identifiable information. We also offer you the option of discontinuing your consent (“opting out” or “unsubscribing”) if you later decide that you no longer want to participate in that program or receive additional information from us. If we wish to use this information for purposes incompatible from those for which the data was initially collected, we will offer an effective way to opt out of the secondary use. Please note that if we share your personally identifiable information with a sponsor or manager of a clinical trial (a “Sponsor”) that Sponsor may continue to have access to your personally identifiable information even if you choose to no longer receive additional information from us.
Demographic and medical information you provide to us may be used and/or shared with third parties in anonymous and aggregated form only.
Antidote requires third parties to whom it discloses personally identifiable information to protect personally identifiable information using substantially similar standards to those required by Antidote. We also require that they do not use your personally identifiable information for any separate use that is not specifically for the execution of the clinical trial or as otherwise authorized by Antidote. There may also be instances where Antidote may be required to share your information with third parties who have not been retained by us (directly or indirectly), as ordered or directed by courts of law or other governmental agencies.
Also, Antidote is obligated to report any Adverse Events identified through the course of the Program to the Sponsor’s Drug Safety for regulatory compliance. In these cases, you are also accepting that the Sponsor may contact your doctor for further information about the adverse event. All information received by Sponsor’s Drug Safety Department is treated in confidence and in accordance with the Privacy laws, and the patient information is de-identified. Adverse Event reports may be forwarded to the relevant health authorities.
Antidote’s assets, whether as a going concern or as part of bankruptcy, liquidation or similar proceeding, in which personally identifiable information held by Antidote about our Site and customers is among the assets transferred.
Antidote stores and processes your personally identifiable information in servers in the European Union (EU). At times Antidote may be required to transfer personally identifiable information in countries other than the country where the information was provided. In these cases, we maintain compliance with applicable data protection and privacy laws and legal frameworks. We protect personally identifiable information entrusted to us no matter what country it is stored in or transferred to and have appropriate safeguards and procedures in place to help ensure the security of your personally identifiable information.
Antidote retains your personally identifiable information for as long as it is necessary to provide services to you, or, until you exercise your Right to Object or withdraw your consent. (opt out) - see Your Privacy below.
Our privacy practices are periodically reviewed by our auditors to verify compliance with this Privacy Statement.
Antidote at all times, follows applicable country, federal and state laws and legal frameworks in effect, to ensure that your personally identifiable information is secure and that your privacy rights are respected and protected.
This covers any collection and processing of your personally identifiable information - see Personally Identifiable Information Collected From You above (including storage, retrieval, use, disclosure/sharing, restriction, blocking and erasure or destruction).
Depending on your country’s specific data laws; you may have the right, without discrimination, at reasonable intervals, to know about your personally identifiable information that Antidote holds (to make a DSAR). Depending on your country’s specific data laws, DSARs may include the right to;
DSARs can be requested by yourself, or on behalf of someone else authorized to do so – such as a parent, appointed guardian, caregiver, or legal representative.
Antidote has a right and an obligation to ask for a written authorization or other documents supporting your DSAR. This is for the purpose of confirming your identity and DSAR eligibility - and any supporting documentation shall be proportionate, and not unduly retained by Antidote for any other purpose.
Antidote also has the right to refuse any manifestly unfounded DSARs - and in such circumstances, shall provide you with a written justification for any refusal. You will have the right to make a complaint to your country supervisory authority at any time.
DSARs are free-of-charge to you for up to two requests within a calendar year. Antidote reserves the right to charge you a reasonable administration/postage fee in the following circumstances:
Antidote is compliant with all US federal and state-specific privacy laws and regulations that govern your personally identifiable information. This includes, but is not limited to;
Commencing January 2023; The California Consumer Privacy Act (CCPA) 2018 - as updated by the California Privacy Rights Act (CPRA) 2020; permits Antidote users that are California residents to access, rectify, update, restrict processing, delete/withdraw their personally identifiable information or opt-out of services.
Additionally, California Civil Code Section § 1798.83 permits California residents to request certain information regarding our disclosure of personally identifiable information to third parties for direct marketing purposes.
Commencing January 2023; the Virginia Consumer Data Protection Act (VCDPA) 2021 permits Antidote users that are Virginia residents to access, rectify, update, restrict processing, delete/withdraw their personally identifiable information or opt-out of services.
Commencing July 2023; the Colorado Privacy Act (CPA) 2021 permits Antidote users that are Colorado residents to access, rectify, update, restrict processing, delete/withdraw their personally identifiable information or opt-out of services.
If you have any questions/requests related to your USA privacy rights, please send an e-mail to: firstname.lastname@example.org.
In accordance with the GDPR; General Data Protection Regulation (EU) 2016/679 citizens of the EU may access, rectify, update, or delete/withdraw their personally identifiable information by sending an e-mail to our European Representative DataRep.
In accordance with the UK the Data Protection Act 2018, the Privacy and Electronic Communications Directive 2002/58/EC (as updated by Directive 2009/136/EC), the Privacy and Electronic Communications Regulations 2003 (SI 2003/2426) and the European Union (Withdrawal) Act 2018; citizens of the UK may access, rectify, update or delete/withdraw their personally identifiable information by sending an e-mail to email@example.com.
Our UK Data Protection Officer (DPO) may be contacted directly via post or email: The Data Protection Officer, Antidote, Office 2.13, Labs - Hogarth House, 136 High Holborn, London WC1V 6PX, United Kingdom – email: firstname.lastname@example.org.
This Privacy Statement was last updated on Oct 24, 2022 – and becomes effective on April 7, 2023.
Antidote may update this Statement from time to time. We encourage you to review our Privacy Statement periodically.